RU2015122748A - Применение штамма lactobacillus rhamnosus для уменьшения прибавления в весе и/или инсулинорезистентности - Google Patents

Применение штамма lactobacillus rhamnosus для уменьшения прибавления в весе и/или инсулинорезистентности Download PDF

Info

Publication number
RU2015122748A
RU2015122748A RU2015122748A RU2015122748A RU2015122748A RU 2015122748 A RU2015122748 A RU 2015122748A RU 2015122748 A RU2015122748 A RU 2015122748A RU 2015122748 A RU2015122748 A RU 2015122748A RU 2015122748 A RU2015122748 A RU 2015122748A
Authority
RU
Russia
Prior art keywords
lactobacillus rhamnosus
strain
insulin resistance
rhamnosus cncm
reduce
Prior art date
Application number
RU2015122748A
Other languages
English (en)
Inventor
Цзянь ШЭНЬ
Цзинцзин ВАН
Липин ЧЖАО
Мартин Саул ОБИН
Мюриель ДЕРРЬЕН
Эмили РОШЕ
ХИЛКАМА ВЛИГ Йохан ВАН
Original Assignee
Компани Жервэ Данон
Тафтс Юниверсити
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Компани Жервэ Данон, Тафтс Юниверсити filed Critical Компани Жервэ Данон
Publication of RU2015122748A publication Critical patent/RU2015122748A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/742Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/175Rhamnosus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Claims (6)

1. Применение штамма Lactobacillus rhamnosus CNCM I-3690 для уменьшения вызванного питанием прибавления в весе и/или вызванной питанием инсулинорезистентности у субъекта.
2. Применение штамма Lactobacillus rhamnosus CNCM I-3690 по п. 1, где указанное применение предназначено для лечения, профилактики или облегчения состояния, возникшего в результате вызванного питанием прибавления в весе и/или вызванной питанием инсулинорезистентности.
3. Применение штамма Lactobacillus rhamnosus CNCM I-3690 по п. 2, где указанное состояние выбрано из избыточного веса, ожирения и связанных с ожирением нарушений.
4. Применение штамма Lactobacillus rhamnosus CNCM I-3690 по п. 1, где указанный штамм содержится в перорально вводимой композиции.
5. Применение штамма Lactobacillus rhamnosus CNCM I-3690 по п. 4, где указанная композиция является пищевым продуктом или пищевой добавкой.
6. Применение штамма Lactobacillus rhamnosus CNCM I-3690 по п. 5, где указанный пищевой продукт является кисломолочным продуктом.
RU2015122748A 2012-11-12 2012-11-12 Применение штамма lactobacillus rhamnosus для уменьшения прибавления в весе и/или инсулинорезистентности RU2015122748A (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2012/084462 WO2014071633A1 (en) 2012-11-12 2012-11-12 Use of lactobacillus rhamnosus strain for reducing weight gain and/or insulin resistance

Publications (1)

Publication Number Publication Date
RU2015122748A true RU2015122748A (ru) 2017-01-10

Family

ID=50683962

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015122748A RU2015122748A (ru) 2012-11-12 2012-11-12 Применение штамма lactobacillus rhamnosus для уменьшения прибавления в весе и/или инсулинорезистентности

Country Status (11)

Country Link
US (1) US10022407B2 (ru)
EP (1) EP2917335B1 (ru)
JP (1) JP2016501010A (ru)
CN (1) CN104870632A (ru)
AR (1) AR093426A1 (ru)
BR (1) BR112015010698A2 (ru)
CA (1) CA2891618A1 (ru)
ES (1) ES2675309T3 (ru)
MX (1) MX2015005898A (ru)
RU (1) RU2015122748A (ru)
WO (1) WO2014071633A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018062914A1 (ko) * 2016-09-30 2018-04-05 씨제이제일제당 (주) 신규한 락토바실러스 사케이 및 이를 포함하는 조성물
US20200155622A1 (en) * 2017-05-22 2020-05-21 Compagnie Gervais Danone Compositions and methods for decreasing a population of bilophila wadsworthia or inhibiting the growth thereof
KR101864347B1 (ko) * 2017-09-06 2018-06-05 주식회사 지놈앤컴퍼니 락토바실러스 람노수스 lm1019 균주 및 이를 포함하는 비만 또는 당뇨병 예방 및 치료용 조성물
WO2019199094A1 (ko) * 2018-04-11 2019-10-17 한국생명공학연구원 비만의 예방 또는 치료 효과를 가지는 신규 비피도박테리움 롱검 균주 또는 락토바실러스 람노서스 균주 및 이의 용도
WO2020006663A1 (zh) * 2018-07-02 2020-01-09 葡萄王生技股份有限公司 用于改善代谢症候群的新颖副干酪乳杆菌 gks6、其培养基、培养方法、用途、医药组合物及可食用组合物
CN109757730B (zh) * 2019-01-31 2021-06-04 山东环亿生物科技有限公司 一种具有降血脂、血压以及血糖的组合物及其制备方法
CN113018319A (zh) * 2021-01-21 2021-06-25 中南大学 一种用于缓解因长期低剂量辐射暴露所致胰岛素抵抗的复合菌剂及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4280016B2 (ja) * 2002-02-28 2009-06-17 雪印乳業株式会社 糖尿病合併症予防・改善・治療剤
US7001756B1 (en) * 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
PT2604689E (pt) 2005-07-26 2015-03-09 Nestec Ltd Agente anti-obesidade e alimento anti-obesidade
ES2693584T3 (es) * 2006-01-27 2018-12-12 Dupont Nutrition Biosciences Aps Uso de microorganismos probióticos para el tratamiento y prevención de obesidad y trastornos relacionados
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
EP2022502A1 (en) 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
FR2928935B1 (fr) * 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
EP2216036A1 (en) 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
EP2216035A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus CNCM I-4096 and weight control
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
FI123157B (fi) * 2009-05-12 2012-11-30 Valio Oy Probioottien uusi käyttö
EA024911B1 (ru) * 2010-01-08 2016-11-30 Компани Жервэ Данон Лактобациллы с антиоксидантным действием

Also Published As

Publication number Publication date
EP2917335B1 (en) 2018-04-04
US10022407B2 (en) 2018-07-17
CA2891618A1 (en) 2014-05-15
JP2016501010A (ja) 2016-01-18
AR093426A1 (es) 2015-06-10
US20150297646A1 (en) 2015-10-22
ES2675309T3 (es) 2018-07-10
WO2014071633A1 (en) 2014-05-15
MX2015005898A (es) 2016-02-05
EP2917335A1 (en) 2015-09-16
EP2917335A4 (en) 2016-06-29
BR112015010698A2 (pt) 2017-07-11
CN104870632A (zh) 2015-08-26

Similar Documents

Publication Publication Date Title
RU2015129066A (ru) Применение bifidobacterium animalis для лечения или предотвращения набора веса и инсулинорезистентности
RU2015122748A (ru) Применение штамма lactobacillus rhamnosus для уменьшения прибавления в весе и/или инсулинорезистентности
WO2014196913A9 (en) Treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimer's disease and inflammatory bowel disease by using at least one bacterial strain from prevotella
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
JP2016537410A5 (ru)
RU2016143195A (ru) Применение lactobacilius rhamnosus для стимулирования восстановления разнообразия кишечной микробиоты после дисбактериоза
RU2015122728A (ru) Штамм lactobacillus rhamnosus для уменьшения накопления жира в организме
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
FI20075539L (fi) Maitohappobakteerit, joilla on proinflammatorisia ominaisuuksia
RU2009134520A (ru) Применение lactobacillus casei для усиления защиты, индуцированной вакцинацией против гриппа
RU2015119462A (ru) Штаммы streptococcus thermophilus для лечения инфекции helicobacter pylori
WO2019220329A8 (en) Probiotic strain lactobacillus kefiri sgl 13 and use thereof for the prevention and treatment of intestinal inflammation and in the prevention of intestinal neoplasms
WO2016008642A3 (en) Compositions comprising cinnamaldehyde and zinc and methods of using such compositions
ATE536102T1 (de) Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus
RU2014108605A (ru) НОВЫЙ ШТАММ L. bulgaricus, СПОСОБНЫЙ ИНГИБИРОВАТЬ АДГЕЗИЮ ШТАММОВ Н. pylori К ЭПИТЕЛИАЛЬНЫМ КЛЕТКАМ
GR20110100600A (el) Λειτουργικες επιτραπεζιες ελιες ζυμωμενες με γαλακτικα βακτηρια που διαθετουν προβιοτικες ιδιοτητες
WO2012021016A3 (ko) 항암 활성을 갖는 락토바실러스 균주 및 이를 활성성분으로 포함하는 항암 활성 조성물
RU2015146979A (ru) Штамм молочнокислой бактерии rhamnosus для регулирования липидного обмена
JP2014101288A5 (ru)
JP2016026473A5 (ru)
WO2012107601A8 (es) Uso de una cepa de lactobacillus bulgaricus para el tratamiento de la inmunosenescencia
MX2013009993A (es) Celulas b. texasporus deficientes de esporulacion y metodos para inactivacion eficiente y rentable y su uso.
TH10629A3 (th) เครื่องดื่มสมุนไพรเข้มข้น
TH10629C3 (th) เครื่องดื่มสมุนไพรเข้มข้น
PH22016000135U1 (en) A composition of sisig from banana blossom

Legal Events

Date Code Title Description
FA94 Acknowledgement of application withdrawn (non-payment of fees)

Effective date: 20170922